Literature DB >> 1151546

Rennes-like variant of galactosemia: clinical and biochemical studies.

G Hammersen, S Houghton, H L Levy.   

Abstract

The first recognized case of a Rennes-like variant form of galactosemia in a Caucasian individual is described. Galactose-1-phosphate uridyl transferase activity was approximately 10% of the normal in both erythrocytes and cultured skin fibroblasts. Electrophoretic mobility of the variant enzyme in erythrocytes was slower than that of normal individuals and identical to that of the two cases originally reported from Rennes, France. In normal cultured skin fibroblasts, four transferase bands were found. In this tissue, the patient again had a slower moving transferase. It is proposed that in transferase variants an altered subunit results in a specifically altered enzyme mobility analogous for each tissue.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1151546     DOI: 10.1016/s0022-3476(75)80067-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

1.  A new genetic variant of galactose-1-phosphate uridyl transferase.

Authors:  R Scherz; R Pflugshaupt; R Bütler
Journal:  Hum Genet       Date:  1976-12-29       Impact factor: 4.132

2.  Temporal gene expression profile in hippocampus of mice treated with D-galactose.

Authors:  Haifeng Wei; Yanning Cai; Jin Chu; Chunyang Li; Lin Li
Journal:  Cell Mol Neurobiol       Date:  2007-08-21       Impact factor: 5.046

Review 3.  Food intolerance in humans.

Authors:  R H Herman; L Hagler
Journal:  West J Med       Date:  1979-02

4.  Polymorphism of erythrocyte galactose-1-phosphate uridyltransferase among Chinese.

Authors:  Y K Xu; W G Ng
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

5.  Biochemical studies of a human low-activity galactose-1-phosphate uridyl transferase variant.

Authors:  W G Ng; F Kline; J Lin; R Koch; G N Donnell
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

6.  Galactose intolerance and the risk of cataract.

Authors:  A F Winder; P Fells; R B Jones; R D Kissun; I S Menzies; J N Mount
Journal:  Br J Ophthalmol       Date:  1982-07       Impact factor: 4.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.